vs
Dominari Holdings Inc.（DOMH）与OptimizeRx Corp（OPRX）财务数据对比。点击上方公司名可切换其他公司
OptimizeRx Corp的季度营收约是Dominari Holdings Inc.的1.1倍（$32.2M vs $30.1M），OptimizeRx Corp净利率更高（15.6% vs -438.1%，领先453.7%），Dominari Holdings Inc.同比增速更快（220.4% vs -0.2%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs 28.0%）
OptimizeRx Corp是一家总部位于美国的数字健康科技企业，为生命科学公司、医疗机构及药房合作伙伴提供患者参与、药物可负担性和临床沟通相关解决方案，核心产品包括数字购药优惠工具、患者支持项目等，助力提升药物可及性与用药依从性。
DOMH vs OPRX — 直观对比
营收规模更大
OPRX
是对方的1.1倍
$30.1M
营收增速更快
DOMH
高出220.6%
-0.2%
净利率更高
OPRX
高出453.7%
-438.1%
两年增速更快
DOMH
近两年复合增速
28.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $30.1M | $32.2M |
| 净利润 | $-131.8M | $5.0M |
| 毛利率 | — | 74.8% |
| 营业利润率 | -8.9% | 26.6% |
| 净利率 | -438.1% | 15.6% |
| 营收同比 | 220.4% | -0.2% |
| 净利润同比 | -12426.2% | 6535.9% |
| 每股收益（稀释后） | $-6.94 | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMHOPRX
| Q4 25 | $30.1M | $32.2M | ||
| Q3 25 | $50.8M | $26.1M | ||
| Q2 25 | $34.1M | $29.2M | ||
| Q1 25 | $8.1M | $21.9M | ||
| Q4 24 | $9.4M | $32.3M | ||
| Q3 24 | $4.0M | $21.3M | ||
| Q2 24 | $6.2M | $18.8M | ||
| Q1 24 | $1.4M | $19.7M |
净利润DOMHOPRX
| Q4 25 | $-131.8M | $5.0M | ||
| Q3 25 | $125.2M | $779.0K | ||
| Q2 25 | $16.6M | $1.5M | ||
| Q1 25 | $-32.5M | $-2.2M | ||
| Q4 24 | $1.1M | $-78.0K | ||
| Q3 24 | $-4.2M | $-9.1M | ||
| Q2 24 | $-6.1M | $-4.0M | ||
| Q1 24 | $-5.4M | $-6.9M |
毛利率DOMHOPRX
| Q4 25 | — | 74.8% | ||
| Q3 25 | — | 67.2% | ||
| Q2 25 | — | 63.8% | ||
| Q1 25 | — | 60.9% | ||
| Q4 24 | — | 68.1% | ||
| Q3 24 | — | 63.1% | ||
| Q2 24 | — | 62.2% | ||
| Q1 24 | — | 62.0% |
营业利润率DOMHOPRX
| Q4 25 | -8.9% | 26.6% | ||
| Q3 25 | -3.1% | 7.9% | ||
| Q2 25 | -57.0% | 10.9% | ||
| Q1 25 | -394.6% | -9.6% | ||
| Q4 24 | 0.4% | 11.2% | ||
| Q3 24 | -79.1% | -40.2% | ||
| Q2 24 | -44.3% | -19.9% | ||
| Q1 24 | -205.2% | -25.5% |
净利率DOMHOPRX
| Q4 25 | -438.1% | 15.6% | ||
| Q3 25 | 246.4% | 3.0% | ||
| Q2 25 | 48.7% | 5.2% | ||
| Q1 25 | -400.5% | -10.0% | ||
| Q4 24 | 11.4% | -0.2% | ||
| Q3 24 | -104.2% | -42.8% | ||
| Q2 24 | -99.1% | -21.3% | ||
| Q1 24 | -398.0% | -35.0% |
每股收益（稀释后）DOMHOPRX
| Q4 25 | $-6.94 | $0.27 | ||
| Q3 25 | $7.27 | $0.04 | ||
| Q2 25 | $1.12 | $0.08 | ||
| Q1 25 | $-3.02 | $-0.12 | ||
| Q4 24 | $0.21 | $0.00 | ||
| Q3 24 | $-0.67 | $-0.50 | ||
| Q2 24 | $-1.01 | $-0.22 | ||
| Q1 24 | $-0.91 | $-0.38 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $80.5M | $23.4M |
| 总债务越低越好 | — | $26.3M |
| 股东权益账面价值 | $69.4M | $128.3M |
| 总资产 | $112.9M | $176.9M |
| 负债/权益比越低杠杆越低 | — | 0.20× |
8季度趋势，按日历期对齐
现金及短期投资DOMHOPRX
| Q4 25 | $80.5M | $23.4M | ||
| Q3 25 | $176.2M | $19.5M | ||
| Q2 25 | $28.2M | $16.6M | ||
| Q1 25 | $18.9M | $16.6M | ||
| Q4 24 | $8.2M | $13.4M | ||
| Q3 24 | $7.2M | $16.1M | ||
| Q2 24 | $12.1M | — | ||
| Q1 24 | $7.1M | — |
总债务DOMHOPRX
| Q4 25 | — | $26.3M | ||
| Q3 25 | — | $28.8M | ||
| Q2 25 | — | $29.3M | ||
| Q1 25 | — | $33.8M | ||
| Q4 24 | — | $34.3M | ||
| Q3 24 | — | $36.8M | ||
| Q2 24 | — | $37.3M | ||
| Q1 24 | — | $37.8M |
股东权益DOMHOPRX
| Q4 25 | $69.4M | $128.3M | ||
| Q3 25 | $210.2M | $122.3M | ||
| Q2 25 | $88.6M | $119.3M | ||
| Q1 25 | $42.4M | $116.3M | ||
| Q4 24 | $39.9M | $117.0M | ||
| Q3 24 | $38.3M | $114.5M | ||
| Q2 24 | $42.4M | $121.0M | ||
| Q1 24 | $47.7M | $122.5M |
总资产DOMHOPRX
| Q4 25 | $112.9M | $176.9M | ||
| Q3 25 | $223.4M | $170.3M | ||
| Q2 25 | $109.3M | $169.3M | ||
| Q1 25 | $52.3M | $167.8M | ||
| Q4 24 | $47.1M | $171.2M | ||
| Q3 24 | $43.4M | $165.2M | ||
| Q2 24 | $49.1M | $172.9M | ||
| Q1 24 | $52.2M | $176.4M |
负债/权益比DOMHOPRX
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.32× | ||
| Q2 24 | — | 0.31× | ||
| Q1 24 | — | 0.31× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.7M | $7.1M |
| 自由现金流经营现金流 - 资本支出 | — | $7.1M |
| 自由现金流率自由现金流/营收 | — | 22.0% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.41× |
| 过去12个月自由现金流最近4个季度 | — | $18.7M |
8季度趋势，按日历期对齐
经营现金流DOMHOPRX
| Q4 25 | $22.7M | $7.1M | ||
| Q3 25 | $-4.9M | $3.2M | ||
| Q2 25 | $-353.0K | $4.6M | ||
| Q1 25 | $1.2M | $3.9M | ||
| Q4 24 | $-16.7M | $198.0K | ||
| Q3 24 | $-4.7M | $1.8M | ||
| Q2 24 | $1.4M | $782.0K | ||
| Q1 24 | $-8.6M | $2.1M |
自由现金流DOMHOPRX
| Q4 25 | — | $7.1M | ||
| Q3 25 | — | $3.2M | ||
| Q2 25 | — | $4.6M | ||
| Q1 25 | — | $3.8M | ||
| Q4 24 | — | $181.0K | ||
| Q3 24 | — | $1.8M | ||
| Q2 24 | — | $737.0K | ||
| Q1 24 | — | $2.1M |
自由现金流率DOMHOPRX
| Q4 25 | — | 22.0% | ||
| Q3 25 | — | 12.2% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 17.5% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | — | 3.9% | ||
| Q1 24 | — | 10.6% |
资本支出强度DOMHOPRX
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.2% |
现金转化率DOMHOPRX
| Q4 25 | — | 1.41× | ||
| Q3 25 | -0.04× | 4.11× | ||
| Q2 25 | -0.02× | 2.98× | ||
| Q1 25 | — | — | ||
| Q4 24 | -15.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
OPRX
暂无分部数据
